Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

BioChem Pharma files first marketing application for lamivudine in hepatitis

Aug. 27, 1997

HemoCleanse receives NIH grant to develop bioartificial liver

Aug. 25, 1997

GalaGen starts Diffistat-G phase II trial

Aug. 18, 1997

Phase I trial of DiffGAM completed successfully

Aug. 18, 1997

More obstacles to Novopharm's launch of generic ranitidine

Aug. 14, 1997

Federal district court favors Geneva in ranitidine patent litigation

Aug. 12, 1997

Complete genomic sequence of H. pylori revealed

Aug. 11, 1997

Study confirms hepatitis B vaccine efficacy

Aug. 8, 1997

YH-439 metabolites identified in rat urine

Aug. 7, 1997

NABI initiates phase II trials of H-BIG for liver transplant patients

Aug. 6, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...